Live Love Laugh with Carol
Contact Carol
  • Home
  • Love Story
  • ALS
  • Blog
  • Tips & Tricks
  • Gallery
  • Travel
  • Media
  • Calendar
  • DONATE

Radicava (Edaravone)

5/12/2017

5 Comments

 
Picture
Breaking News!
On May 5, 2017 the US food & drug administration (FDA) approved a new drug to treat ALS!  Radicava (Edaravone) is the first new treatment approved in 22 years!  For me, however, I see it as the only treatment option offered in over 100 years of the existence of ALS.  I say that because Rilutek (Riluzole), a drug that is used for ALS in both the US and Canada only seems to extend the patient's life for a few months, and who wants to live 3 months longer when you are paralyzed?  That and the fact that I am unable to take it as I also have a liver condition.

Edaravone was initially used in Japan to treat stroke.  In a 6 month clinical trial in Japan, they demonstrated that edaravone could slow progression by up to 33%!  Now the clinical trial only had 137 participants, half of which received placebo.  While not a huge study, it still gives me hope, imagine if my progression could slow by 33%, I find that incredibly significant.

The US FDA approached the Japanese drug developer Mitsubishi Tanabe about filing a marketing application in the US.  It will be available for use in the US this August 2017!  Let's hope that Canada reaches out to them as well, for the company to seek approval with Health Canada.

The difficulties with the treatment are that it requires an intravenous infusion for 14 days, followed by a 14 day drug free period, with subsequent treatment cycles.  Also the high cost (about $145,000 US/year, not sure what the cost would be if approved in Canada), and of course the possibility of adverse reactions.

I am aware of the fact that this new drug may not be available to me specifically, and there are many challenges involved with receiving it, however, to see a new drug approved for the treatment of ALS in my lifetime, was something I never thought I would see.  I'm not saying that I don't have hope, it's just that with such a short life-span of living with ALS, I was advocating on behalf of those who will be diagnosed with ALS in the future.  But I guess treatment and a cure has to happen during someone's lifetime!  

This development may also spur momentum for drug companies to pursue the development of additional treatment options.  And if Radicava actually significantly reduces progression, then what elements of the drug contribute to the slowing of ALS?  What an incredible opportunity for researchers to study this potential breakthrough!

All in all, this is a heartening and encouraging discovery to me, quite awesome in fact!

These are just my thoughts after hearing the news, for actual facts, I have included several articles on the release of Radicava (Eradavone) below.

ALS Canada
FDA
ALS Association
ALS TDI
CNN
5 Comments
Heather
5/12/2017 06:10:59 pm

Amazing! Progress! Hope! 🍾
Cheers to possibility - potential is so much brighter than nothing xxoo

Reply
Dad - Allan
5/22/2017 09:01:51 pm

33% - wow that seems pretty significant. A step in the right direction is encouraging. You have set out the issues realistically and succinctly Carol. Thank you for that.
Much love.

Reply
Jeannette Niggenaber
9/15/2017 07:56:51 pm

Let's get it in Canada. Not fair

Reply
Mike
9/18/2017 06:22:59 pm

I just started use of this new drug on Friday and have nothing but hope and prayers that it does slow progress. Some side effects I have had include nausea (which I'm not convinced it is the drug at this time), increased fatigue and a slight hypersensitivity. Good Luck to you!

Reply
Celeste
9/24/2017 10:02:04 pm

Mike, how are you doing now after taking the Radicava for awhile?

Reply



Leave a Reply.

    Author

    Carol Jean Skinner (née Sharman)
    born October 19
    lives in Ottawa, Canada

    Archives

    September 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013

    RSS Feed

carol skinner  - rolyskinner@gmail.com
travis skinner - skinnertravis@gmail.com